Latest Breaking News On - Pharma outlook 2024 - Page 1 : vimarsana.com

In today s trade, Lupin s shares soared nearly 7%, hitting a new all-time high of ₹1,404 apiece after Japanese brokerage firm Nomura raised the target price on the stock to ₹1,593 apiece from the previous ₹1,290, maintaining its buy recommendation.

India
United-states
Japan
Japanese
Prathamesh-masdekar
Sun-pharma
Motilal-oswal
Aurobindo-pharma
Zydus-lifesciences
Research-analyst-at-stoxbox
Glenmark-pharmaceuticals
Glaxosmithkline-pharmaceuticals